Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
Reports on the treatment of bleeding associated with emicizumab administration are scarce. Herein, we report the case of an eight-year-old boy with moderate hemophilia A with an inhibitor who experienced tonsillar hemorrhage while undergoing emicizumab treatment. He visited our hospital for postpran...
Main Authors: | Fumiya Inoue, Kazuki Terada, Kazuki Furudate, Yasushi Noguchi, Shunji Igarashi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2038-8330/14/2/16 |
Similar Items
-
Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020-01-01) -
Emicizumab Associated Rhabdomyolysis in Hemophilia A
by: Joseph A. Wilson, et al.
Published: (2020-10-01) -
Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors
by: Giancarlo Castaman, et al.
Published: (2024-01-01) -
Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
by: Brinza Melen, et al.
Published: (2024-01-01) -
Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab
by: Víctor Jiménez-Yuste, et al.
Published: (2024-04-01)